This guidance is intended to assist manufacturers in assuring the control of microbiological2 quality of their non-sterile drugs (NSDs).The recommendations herein apply to solid non18 sterile dosage forms, as well as semi-solid, and liquid non-sterile dosage forms (e.g., topicallyapplied creams, lotions and swabs, and oral solutions and suspensions).